Rhythm Pharmaceuticals Inc’s recent filing unveils that its Officer JOSEPH SHULMAN acquired Company’s shares for reported $0.37 million on Aug 11 ’25. In the deal valued at $91.98 per share,3,984 shares were bought.
Then, Cramer Pamela J. sold 1,520 shares, generating $130,614 in total proceeds. Upon selling the shares at $85.93, the Chief Human Resources Officer now owns 20,814 shares.
Before that, Smith Hunter C sold 42,120 shares. Rhythm Pharmaceuticals Inc shares valued at $3,389,756 were divested by the Chief Financial Officer at a price of $80.48 per share. As a result of the transaction, Smith Hunter C now holds 116,915 shares, worth roughly $11.03 million.
Goldman initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on July 10, 2025; the price target was $97. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. BofA Securities also remained covering RYTM and has increased its forecast on April 07, 2025 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of RYTM
On Monday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock jump 2.53% to $94.31. Over the last five days, the stock has gained 4.51%. Rhythm Pharmaceuticals Inc shares have risen nearly 116.51% since the year began. Nevertheless, the stocks have risen 68.47% over the past one year. While a 52-week high of $94.80 was reached on 07/10/25, a 52-week low of $43.57 was recorded on 04/07/25.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 90.88, which if violated will result in even more drops to 87.45. On the upside, there is a resistance level at 96.06. A further resistance level may holdings at 97.82.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-07-15, growing by 32000.0 shares to a total of 4.79 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.76 million shares. There was a rise of 0.67%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 02, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $80 price target.
